These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6319045)

  • 41. Global and regional hemodynamic effects of ramipril in congestive heart failure.
    Crozier IG; Ikram H; Nicholls MG; Jans S
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):688-93. PubMed ID: 2481181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of hormonal and haemodynamic changes after long-term oral therapy with pimobendan or enalapril--a double-blind randomized study.
    Erlemeier HH; Kupper W; Bleifeld W
    Eur Heart J; 1991 Aug; 12(8):889-99. PubMed ID: 1915427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemodynamic effects of captopril in patients with severe chronic heart failure.
    LeJemtel TH; Keung E; Frishman WH; Ribner HS; Sonnenblick EH
    Am J Cardiol; 1982 Apr; 49(6):1484-8. PubMed ID: 7041587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemodynamic, hormonal, and pharmacokinetic aspects of treatment with lisinopril in congestive heart failure.
    Dickstein K
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S73-81. PubMed ID: 2442558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemodynamic changes and renal plasma flow in early heart failure: implications for renin, aldosterone, norepinephrine, atrial natriuretic peptide and prostacyclin.
    Holmer SR; Riegger AJ; Notheis WF; Kromer EP; Kochsiek K
    Basic Res Cardiol; 1987; 82(2):101-8. PubMed ID: 2955780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
    Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA
    Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.
    Sharpe DN; Murphy J; Coxon R; Hannan SF
    Circulation; 1984 Aug; 70(2):271-8. PubMed ID: 6329547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostacyclin therapy in patients with congestive heart failure.
    Yui Y; Nakajima H; Kawai C; Murakami T
    Am J Cardiol; 1982 Aug; 50(2):320-4. PubMed ID: 7048886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of minoxidil on hemodynamics in patients with congestive heart failure.
    Franciosa JA; Cohn JN
    Circulation; 1981 Mar; 63(3):652-7. PubMed ID: 7006852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of bromocriptine in patients with congestive heart failure.
    Francis GS; Parks R; Cohn JN
    Am Heart J; 1983 Jul; 106(1 Pt 1):100-6. PubMed ID: 6346844
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The acute hemodynamic, hormonal, and pharmacokinetic properties of oral spirapril in patients with moderate to severe heart failure.
    van den Broek SA; van Bruggen A; de Graeff PA; Hillege H; van Gilst WH; Wesseling H; Lie KI
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):614-21. PubMed ID: 1724540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
    Levine TB; Cohn JN
    Am Heart J; 1982 Nov; 104(5 Pt 2):1159-64. PubMed ID: 6182784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful management of severe congestive cardiac failure with enalapril.
    Dickstein K; Gundersen T
    Am J Med; 1983 Oct; 75(4):721-3. PubMed ID: 6312795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme.
    Davis R; Ribner HS; Keung E; Sonnenblick EH; LeJemtel TH
    N Engl J Med; 1979 Jul; 301(3):117-21. PubMed ID: 221810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized cross-over study of enalapril in congestive heart failure: haemodynamic and hormonal effects during rest and exercise.
    Mulligan IP; Fraser AG; Tirlapur V; Lewis MJ; Newcombe RG; Henderson AH
    Eur J Clin Pharmacol; 1988; 34(4):323-31. PubMed ID: 2841136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemodynamic results of perorally administered converting enzyme inhibitors in congestive heart failure.
    Lantz P; Enghoff E; Hedlund A; Hägg A
    Scand J Urol Nephrol Suppl; 1984; 79():129-32. PubMed ID: 6089312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
    Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A
    Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure.
    Jamison M; Widerhorn J; Weber L; Campese V; Vasquez J; Hovanessian L; Rahimtoola SH; Elkayam U
    Am Heart J; 1989 Mar; 117(3):607-14. PubMed ID: 2537556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.
    Drexler H; Banhardt U; Meinertz T; Wollschläger H; Lehmann M; Just H
    Circulation; 1989 Mar; 79(3):491-502. PubMed ID: 2521816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term haemodynamic effects of enalapril at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P
    Scand J Urol Nephrol Suppl; 1984; 79():87-91. PubMed ID: 6089323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.